Navigation Links
Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
Date:10/24/2013

nable to continue marketing or developing a product or may result in Shire being unable to do so on a commercially viable basis;
  • Shire uses third party manufacturers to manufacture many of its products and is reliant upon third party contractors for certain goods and services, and any inability of these third party manufacturers to manufacture products, or any failure of these third party contractors to provide these goods and services, in each case in accordance with its respective contractual obligations, could adversely affect Shire's ability to manage its manufacturing processes or to operate its business;
  • the development, approval and manufacturing of Shire's products is subject to extensive oversight by various regulatory agencies and regulatory approvals or interventions associated with changes to manufacturing sites, ingredients or manufacturing processes could lead to significant delays, increase in operating costs, lost product sales, an interruption of research activities or the delay of new product launches;
  • the actions of certain customers could affect Shire's ability to sell or market products profitably and fluctuations in buying or distribution patterns by such customers could adversely impact Shire's revenues, financial conditions or results of operations;
  • investigations or enforcement action by regulatory authorities or law enforcement agencies relating to Shire's activities in the highly regulated markets in which it operates may result in the distraction of senior management, significant legal costs and the payment of substantial compensation or fines;
  • adverse outcomes in legal matters and other disputes, including Shire's ability to obtain, maintain, enforce and defend patents and other intellectual property rights required for its business, could have a material adverse effect on Shire's revenues, financial condition or results of operations;

  • and other risks and uncertainties deta
    '/>"/>

    SOURCE Shire plc
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

    Related biology technology :

    1. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
    2. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
    3. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
    4. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
    5. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
    6. Shire Changes its NASDAQ Ticker Symbol to SHPG
    7. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
    8. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
    9. Shire Reaches Agreement in Principle With U.S. Government
    10. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
    11. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
    (Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
    (Date:7/24/2014)... 24, 2014 The first part of ... in First in Human Studies” will cover comprehensive clinical ... decisions. , With increasing R&D costs and declining industry ... to maximize the knowledge collected in early Phase I/IIa ... success in late stage development. , Next, the presenters ...
    (Date:7/24/2014)... As part of the long-term strategic approach, ... region during 2014 with potential global expansion. , "We ... DZS to manage our clinical trials globally and in ... R&D and President of SBI pharmaceuticals MENA, Dr. Riyadh ... a focus on utilizing eClinical software and flexible team ...
    Breaking Biology Technology:Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2
    ... Mano Receive 2008 JCA-Mauvernay Award, LAUSANNE, ... global biopharmaceutical development specialist that,focuses on serious ... Ichijo and Hiroyuki Mano with the 2008 ... research work in oncology.,The Awards were presented ...
    ... Preclinical Animal Data Demonstrates Selective Survival Advantage of ... Reduced Viral Loads, WASHINGTON and RICHMOND, Calif., ... ) announced today the presentation,of data demonstrating that ... HIV infection by treatment with zinc finger DNA-binding,protein ...
    ... Growth in Core ... Clinical Business, SUNNYVALE, Calif., Oct. 28 ... of $44.9,million, an increase of 24% over the third quarter of fiscal ... revenue of $36.3,million and a net loss of $4.7 million, or $(0.09) ...
    Cached Biology Technology:Japanese Cancer Association and Debiopharm Honour Japanese Research 2Japanese Cancer Association and Debiopharm Honour Japanese Research 3Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13
    (Date:7/24/2014)... drug that successfully treated lupus in mice, a biomedical engineer ... to expand his research to a new version of the ... autoimmune diseases., Chandra Mohan, Hugh Roy and Lillie Cranz Cullen ... study in Arthritis Research & Therapy outlining the use of ... reduced the number of cases of lupus-related kidney disease., He ...
    (Date:7/24/2014)... virus living inside your gut that has gone undetected ... researchers at San Diego State University has found that ... a newly described virus, named crAssphage, which infects one ... Bacteroidetes . This phylum of bacteria is thought to ... The research appears today in Nature Communications ., ...
    (Date:7/23/2014)... the pitcher, a thirsty bird happens upon a vessel of ... finds the water level out of his reach. Not strong ... into it one at a time until the ... , Highlighting the value of ingenuity, the fable demonstrates that ... It also characterizes crows as pretty resourceful problem solvers. New ...
    Breaking Biology News(10 mins):Biomedical engineer looks at new applications for novel lupus drug 2Biomedical engineer looks at new applications for novel lupus drug 3Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4
    ... and China has produced a first draft of the papaya ... of the plants gene coding sequence, sheds new light on ... genetically modified plant, the newly sequenced papaya genome offers the ... the plant resistant to the papaya ringspot virus. The ...
    ... with good oral health could become the first tool ... to periodontal disease treatments, say researchers at the University ... called HtpG, the bug that makes it is Porphyromonas ... also has potential as a vaccine candidate, according to ...
    ... the University Hospital of Magdeburg (Germany) have discovered ... and oxidative stress followed by the activation of ... target gene expression in atrial tissue. Their study ... Experimental Biology and Medicine. Multiple tachycardia-associated factors appear ...
    Cached Biology News:First draft of transgenic papaya genome yields many fruits 2First draft of transgenic papaya genome yields many fruits 3Presence of certain antibodies signals healthier teeth and gums 2Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia 2
    ANTI CORTIS BIN GLOB...
    MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
    ANTI S. ENTERID LPS...
    ... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
    Biology Products: